CapsoVision director granted 4,045 RSUs

Imperial Joanne Carol reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Imperial Joanne Carol reported acquisition or exercise transactions in this Form 4 filing.

CapsoVision, Inc director Joanne Carol Imperial received a grant of 4,045 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of CapsoVision common stock.

The award vests in two equal installments: 50% on June 30, 2026 and 50% on December 31, 2026, subject to her continued service as a non-employee director through each vesting date. Following this grant, she holds 4,045 RSUs directly, and this filing reflects a compensation-related award rather than an open-market share purchase or sale.

Insider Trade Summary

Grant/Award: 4,045 shares

Grant/Award 1 txn

Insider Imperial Joanne Carol

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit (RSU)	4,045	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit (RSU) — 4,045 contracts (Direct)

Footnotes (2)

1. F1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
2. F2. These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) report for Joanne Carol Imperial?

CapsoVision reported that director Joanne Carol Imperial received 4,045 Restricted Stock Units as a compensation award. These RSUs are not a market purchase or sale but a grant that can convert into common shares if the vesting conditions are satisfied.

How many RSUs did CapsoVision (CV) grant to its director in this Form 4?

The director was granted 4,045 Restricted Stock Units. Each RSU represents a contingent right to one share of CapsoVision common stock, meaning she can receive up to 4,045 shares if all vesting conditions are met over time.

When do Joanne Carol Imperial’s CapsoVision (CV) RSUs vest?

The RSUs vest in two equal tranches: 50% on June 30, 2026 and 50% on December 31, 2026. Vesting is conditioned on her continued service on CapsoVision’s board as a non-employee director through each respective vesting date.

Is the CapsoVision (CV) Form 4 transaction a stock purchase or sale?

The Form 4 reflects a grant of 4,045 Restricted Stock Units, not an open-market stock purchase or sale. It is a compensation-related award with a zero dollar grant price that may settle in shares upon vesting, subject to service conditions.

What does each CapsoVision (CV) RSU granted to the director represent?

Each RSU represents a contingent right to receive one share of CapsoVision common stock. The director only receives the underlying shares if the RSUs vest according to schedule and she continues serving on the board through the specified vesting dates.

What is Joanne Carol Imperial’s position in CapsoVision (CV) after this RSU grant?

After the grant, she holds 4,045 Restricted Stock Units directly. These RSUs are derivative equity awards rather than already-issued common shares, and they can convert into an equal number of common shares if future vesting conditions are fulfilled.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 06:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Imperial Joanne Carol

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	(1)	03/19/2026		A		4,045		(2)	(2)	Common Stock	4,045	$0	4,045	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Joanne Imperial	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)